GW&K Investment Management LLC Decreases Holdings in Integer Holdings Corporation (NYSE:ITGR)

GW&K Investment Management LLC reduced its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 0.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 431,000 shares of the medical equipment provider's stock after selling 2,531 shares during the period. GW&K Investment Management LLC owned approximately 1.24% of Integer worth $50,862,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Cooke & Bieler LP raised its position in shares of Integer by 6.3% during the first quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider's stock worth $37,456,000 after acquiring an additional 18,790 shares during the last quarter. Edgestream Partners L.P. grew its stake in Integer by 208.4% in the first quarter. Edgestream Partners L.P. now owns 36,729 shares of the medical equipment provider's stock valued at $4,334,000 after purchasing an additional 24,819 shares in the last quarter. MQS Management LLC acquired a new stake in shares of Integer in the first quarter valued at approximately $272,000. New York State Common Retirement Fund lifted its position in shares of Integer by 7.4% in the first quarter. New York State Common Retirement Fund now owns 249,847 shares of the medical equipment provider's stock valued at $29,484,000 after buying an additional 17,278 shares during the last quarter. Finally, Laurus Global Equity Management Inc. increased its stake in shares of Integer by 16.8% during the first quarter. Laurus Global Equity Management Inc. now owns 47,770 shares of the medical equipment provider's stock worth $5,637,000 after purchasing an additional 6,855 shares during the period. 99.29% of the stock is owned by institutional investors.

Integer Price Performance

Shares of ITGR traded down $0.92 during trading hours on Monday, hitting $111.57. The stock had a trading volume of 345,968 shares, compared to its average volume of 389,901. The company's fifty day moving average is $119.65 and its two-hundred day moving average is $124.34. The stock has a market capitalization of $3.89 billion, a price-to-earnings ratio of 52.88, a P/E/G ratio of 0.97 and a beta of 0.98. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.40 and a quick ratio of 2.14. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same period last year, the business earned $1.14 EPS. The business's quarterly revenue was up 7.3% on a year-over-year basis. On average, analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Activity

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 362,434 shares of company stock valued at $44,577,115. 2.16% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have commented on ITGR shares. Raymond James Financial boosted their price objective on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Truist Financial set a $150.00 price target on Integer and gave the company a "buy" rating in a research report on Friday, April 25th. Benchmark lowered their price target on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and lifted their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, KeyCorp cut their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Integer currently has an average rating of "Moderate Buy" and an average target price of $146.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.